The integrase inhibitor elvitegravir ( EVG ) has been co-formulated with the CYP3A4 inhibitor cobicistat ( COBI ) , emtricitabine ( FTC ) , and tenofovir disoproxil fumarate ( TDF ) in a single tablet given once daily .
